Digital technologies, machine learning and Artificial Intelligence (AI) are revolutionizing the fields of medicine, research and public health in an unprecedented manner. While holding great promise, this rapidly developing field raises a number of ethical, legal and social concerns, e.g. regarding equitable access, privacy, appropriate uses and users, liability and bias and inclusiveness. These issues are trans-national in nature, as capturing, sharing and using data generated and/or used by these technologies goes beyond national boundaries. The tools, methods and technologies used in “Big Data” and AI are being applied to improve health services and systems. However, many questions remain unanswered concerning the ethical development and use of these technologies, including how low- and middle-income countries will benefit from AI developments.
Project
In September 2019, the WHO Director General, with the support of the Chief Scientist, and led by two Departments in the Science Division - Digital Health and Innovation and Research for Health - appointed and convened a new expert group to address the growing use of AI in health care. The Expert Group includes leading experts in ethics, digital technology, law, human rights, as well as experts from Ministries of Health. Since then, the Expert Group has guided WHO to publish several leading guidance documents, publications, and policy reports on the ethics and governance of AI for health.
Publications

Ethics and governance of artificial intelligence for health: Guidance on large multi-modal models
Artificial Intelligence (AI) refers to the capability of algorithms integrated into systems and tools to learn from data so that they can perform automated...

The WHO guidance on Ethics & Governance of Artificial Intelligence for Health is the product of eighteen months of deliberation amongst leading experts...

Benefits and risks of using artificial intelligence for pharmaceutical development and delivery
WHO recognizes that artificial intelligence (AI) holds great promise for pharmaceutical development and delivery. However, AI also presents risks and ethical...

Ageism in artificial intelligence for health
The WHO policy brief Ageism in artificial intelligence for health examines the use of artificial intelligence (AI) in medicine and public health for older...

Ethical considerations to guide the use of digital proximity tracking technologies for COVID-19 contact...
Digital proximity tracking technologies have been identified as a potential tool to support contact tracing for COVID-19. However, these technologies raise...

Big data and artificial intelligence for achieving universal health coverage: an international consultation...
WHO and the University of Miami Miller School of Medicine Institute for Bioethics and Health Policy have long collaborated in identifying and addressing...
Members of the Expert Group
Related groups